ArticleCancer control : journal of the Moffitt Cancer Center

Efficacy and Safety of Anlotinib and PD-1/L1 Inhibitors as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer Patients who Have Achieved Stable-Disease After First-Line Treatment with Chemotherapy and Immunotherapy: A Retrospective Study.

Yi Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.